Zenflow Raises $31.4M in Series A Funding
Zenflow, Inc., a San Francisco, CA-based medical device company, closed a $31.4m Series A equity financing round.
The round was led by Invus Opportunities, F-Prime Capital Partners, and Medical Technology Venture Partners.
The company, which has also received grant funding from the National Institutes of Health (NIH) and National Science Foundation (NSF).
Founded by Nick Damiano and Shreya Mehta out of the Stanford Biodesign Innovation Fellowship in 2014, Zenflow develops minimally invasive devices to treat obstructive urinary symptoms related to benign prostatic hyperplasia (BPH or enlarged prostate). Its first product is the Spring System, a technology device that delivers a low-profile superelastic implant into the prostatic urethra. This system is intended to permanently relieve BPH symptoms in a single procedure with fast recovery and minimal side effects.Back to News